Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Xcel Energy Inc (XEL) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Xcel Energy IncTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Xcel Energy Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Xcel Energy Inc trades at $75.55 (market cap $46.62B). The key difference: Xcel Energy Inc is far larger — about 11.2× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Xcel Energy Inc pays a 3.18% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Xcel Energy Inc for 61 Days on average.

INDVXEL
Market Cap
$4.18B$46.62B
Volume
1,819,7464,168,668
Sector
HealthUtilities
52-Week High
$41.83$83.91
52-Week Low
$24.09$69.39
Typical Hold Time
0 Days61 Days
Enterprise Value
$4.47B$84.94B
Dividend Yield
—3.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Xcel Energy Inc

Xcel Energy (XEL) trades at $75.36, up 1.6% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings show mixed results with a Q2 2026 beat (EPS $0.93 vs. $0.79 expected) but a Q4 2025 miss. Revenue for 2025 was $14.67B with a net income margin of 15.28%, while the company maintains a P/E of 20.45 and ROE of 9.92%. News highlights include partnerships for electric school buses and growth from data center power demand.

The outlook is positive, supported by a $60 billion capital expenditure plan and rising power demand, offering potential upside to the $90.58 consensus price target. Key risks include wildfire liabilities, high debt levels, and regulatory scrutiny. The stock presents a balanced opportunity for income and growth investors, with a dividend yield around 3.3% and institutional accumulation noted in recent filings.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
XEL
100% Buy0% Sell
Avg holding period · 61 Days

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Xcel Energy Inc

Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan

Read more on XEL →